(Q53223315)

12 May 2018

title

Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease. (English)

1 reference

12 May 2018

main subject

chronic liver disease

0 references

author

Utaroh Motosugi

1

1 reference

12 May 2018

author name string

Tomoaki Ichikawa

2

1 reference

12 May 2018

Katsuhiro Sano

3

1 reference

12 May 2018

Hironobu Sou

4

1 reference

12 May 2018

Kojiro Onohara

5

1 reference

12 May 2018

Ali Muhi

6

1 reference

12 May 2018

Fumitake Amemiya

7

1 reference

12 May 2018

Nobuyuki Enomoto

8

1 reference

12 May 2018

Masanori Matsuda

9

1 reference

12 May 2018

Hideki Fujii

10

1 reference

12 May 2018

Tsutomu Araki

11

1 reference

12 May 2018

publication date

23 May 2011

1 reference

12 May 2018

Journal of Magnetic Resonance Imaging

published in

1 reference

12 May 2018

volume

34

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

88-94

1 reference

12 May 2018

Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Diagnosis of small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Consensus report of the 2nd International Forum for Liver MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatoce

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

Imaging Characteristics of Hepatocellular Carcinoma Using the Hepatobiliary Contrast Agent Gd-EOB-DTPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22630

21 January 2018

Identifiers

DOI

10.1002/JMRI.22630

1 reference

12 May 2018

1 reference

12 May 2018